Samsara BioCapital, LLC - BIONTECH SE ownership

BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 283 filers reported holding BIONTECH SE in Q2 2021. The put-call ratio across all filers is 1.46 and the average weighting 0.3%.

Quarter-by-quarter ownership
Samsara BioCapital, LLC ownership history of BIONTECH SE
ValueSharesWeighting
Q1 2022$688,000
-33.8%
4,0310.0%0.17%
-14.4%
Q4 2021$1,039,000
-33.9%
4,031
-30.0%
0.20%
-18.2%
Q3 2021$1,572,000
+22.0%
5,7580.0%0.25%
+55.3%
Q2 2021$1,289,000
+9.3%
5,758
-46.7%
0.16%
-26.7%
Q1 2021$1,179,000
+34.0%
10,7950.0%0.22%
+146.6%
Q4 2020$880,000
+0.1%
10,795
-15.0%
0.09%
-64.1%
Q3 2020$879,00012,7000.24%
Other shareholders
BIONTECH SE shareholders Q2 2021
NameSharesValueWeighting ↓
Fosun International Ltd 1,580,777$407,524,00023.29%
Bill & Melinda Gates Foundation 148,674$38,300,00011.62%
Pendal Group Ltd 1,955,940$504,241,0004.04%
Darwin Global Management, Ltd. 90,057$23,217,0003.55%
Connective Portfolio Management, LLC 7,460$1,923,0003.38%
Baader Bank Aktiengesellschaft 157,160$40,509,0003.11%
PARUS FINANCE (UK) Ltd 32,754$8,444,0002.71%
MARK ASSET MANAGEMENT LP 89,942$23,187,0002.64%
ELEMENT CAPITAL MANAGEMENT LLC 155,607$40,115,0002.58%
Renaissance Capital LLC 32,829$8,463,0002.17%
View complete list of BIONTECH SE shareholders